Ingredion Incorporated $INGR Stake Decreased by JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered its holdings in shares of Ingredion Incorporated (NYSE:INGR) by 7.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 393,923 shares of the company’s stock after selling 31,410 shares during the period. JPMorgan Chase & Co. owned approximately 0.61% of Ingredion worth $48,102,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the stock. PNC Financial Services Group Inc. lifted its position in Ingredion by 0.7% in the third quarter. PNC Financial Services Group Inc. now owns 25,202 shares of the company’s stock worth $3,077,000 after purchasing an additional 179 shares during the period. HighTower Advisors LLC lifted its stake in Ingredion by 1.9% during the third quarter. HighTower Advisors LLC now owns 15,070 shares of the company’s stock valued at $1,840,000 after buying an additional 276 shares in the last quarter. Metis Global Partners LLC boosted its holdings in shares of Ingredion by 34.1% in the third quarter. Metis Global Partners LLC now owns 7,427 shares of the company’s stock worth $907,000 after buying an additional 1,888 shares during the period. Assetmark Inc. increased its position in shares of Ingredion by 1.1% in the third quarter. Assetmark Inc. now owns 651,096 shares of the company’s stock worth $79,505,000 after acquiring an additional 6,886 shares in the last quarter. Finally, Illinois Municipal Retirement Fund raised its holdings in shares of Ingredion by 11.8% during the third quarter. Illinois Municipal Retirement Fund now owns 30,270 shares of the company’s stock valued at $3,696,000 after acquiring an additional 3,188 shares during the period. 85.27% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Ingredion

In related news, SVP Larry Fernandes sold 3,630 shares of the firm’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $118.40, for a total value of $429,792.00. Following the transaction, the senior vice president directly owned 32,055 shares in the company, valued at approximately $3,795,312. This trade represents a 10.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO James P. Zallie sold 33,597 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $119.66, for a total transaction of $4,020,217.02. Following the transaction, the chief executive officer directly owned 50,167 shares of the company’s stock, valued at approximately $6,002,983.22. This represents a 40.11% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 48,311 shares of company stock worth $5,741,840. Corporate insiders own 2.30% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on INGR. BMO Capital Markets reiterated a “market perform” rating on shares of Ingredion in a research report on Wednesday, February 4th. Barclays lifted their price target on Ingredion from $124.00 to $128.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. Wall Street Zen downgraded Ingredion from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. UBS Group raised their price objective on Ingredion from $119.00 to $124.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Ingredion in a report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, Ingredion presently has an average rating of “Hold” and a consensus price target of $125.83.

Ingredion Trading Up 0.6%

Shares of NYSE:INGR opened at $117.18 on Friday. The stock has a market capitalization of $7.38 billion, a PE ratio of 10.50, a P/E/G ratio of 0.92 and a beta of 0.71. Ingredion Incorporated has a 1 year low of $102.31 and a 1 year high of $141.78. The firm has a fifty day moving average price of $115.13 and a 200 day moving average price of $117.05. The company has a current ratio of 2.66, a quick ratio of 1.73 and a debt-to-equity ratio of 0.41.

Ingredion (NYSE:INGR) last posted its earnings results on Tuesday, February 3rd. The company reported $2.53 earnings per share for the quarter, missing the consensus estimate of $2.59 by ($0.06). The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.78 billion. Ingredion had a net margin of 10.10% and a return on equity of 17.32%. Ingredion’s quarterly revenue was down 2.4% on a year-over-year basis. During the same quarter last year, the business earned $2.63 earnings per share. Ingredion has set its FY 2026 guidance at 11.000-11.8 EPS. Analysts expect that Ingredion Incorporated will post 11.14 EPS for the current fiscal year.

Ingredion Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, January 20th. Shareholders of record on Friday, January 2nd were given a dividend of $0.82 per share. The ex-dividend date of this dividend was Friday, January 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 2.8%. Ingredion’s dividend payout ratio is presently 29.39%.

Ingredion Profile

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.